The suppression of the endogenous WFDC2 in ovarian cancer cells not only inhibited cell growth, but also significantly strengthened the response of estrogen-insensitive SKOV3 cells to estrogen. This evidence concerns the gene WFDC2 and ovarian carcinoma.